Labcorp Holdings Inc.
HealthcareNYSE:LH · New York Stock Exchange
+$0.89 today
Vol 0.37M · Avg 0.63M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+3.01%
Period High
$288.63
Period Low
$240.50
Latest
$266.16
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Biogen Inc.
NASDAQ:BIIB
$29.53B
DexCom, Inc.
NASDAQ:DXCM
$29.08B
Illumina, Inc.
NASDAQ:ILMN
$24.35B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.23B
Waters Corporation
NYSE:WAT
$23.17B
United Therapeutics Corporation
NASDAQ:UTHR
$23.17B
Quest Diagnostics Incorporated
NYSE:DGX
$22.48B
Incyte Corporation
NASDAQ:INCY
$21.68B
STERIS plc
NYSE:STE
$20.26B
Zimmer Biomet Holdings, Inc.
NYSE:ZBH
$17.13B
What is the latest LH filing?
The latest filing shown is 4 dated Jun 10, 2026.
How many recent filings does LH have?
Intrinsic Alpha currently shows 20 recent filings for LH.
Explore More
Continue the stock analysis
Jump to another research area for this company.